Skip to main content

FDA authorizes use of blood plasma to treat COVID-19 patients

The U.S. Food and Drug Administration (FDA) has authorized the use of convalescent blood plasma in the treatment of COVID-19 patients.

The FDA’s emergency use authorization (EUA) comes amid ongoing pressure from President Trump for organizations to speed up drug development and testing to fight COVID-19. Trump praised the agency’s decision at a White House press conference on Sunday, August 23.

Different from a vaccine, convalescent plasma is one of a number of treatments that are being tested in clinical trials. The method extracts antibody-rich plasma from people who have recovered from COVID-19 and transfers it to a patient with the condition. In successful cases, the plasma will boost the patient’s immune system, giving them the strength to fight the virus until their body is able to make its own antibodies.

In a statement posted online on Sunday, the FDA said “it is reasonable to believe that COVID-19 convalescent plasma may be effective in lessening the severity or shortening the length of COVID-19 illness in some hospitalized patients,” adding, “The known and potential benefits of the product outweigh the known and potential risks of the product.”

However, the FDA cautioned that convalescent plasma “does not yet represent a new standard of care based on the current available evidence,” and so it therefore “continues to recommend that the designs of ongoing randomized clinical trials of COVID-19 convalescent plasma and other therapeutic agents remain unaltered.”

In a tweet posted by Trump on Saturday — the day before the FDA issued the convalescent plasma EUA — the president wrote: “The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics. Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!” He also tagged in Stephen Hahn, the agency’s commissioner.

At Sunday’s press conference, with Hahn standing close by, Trump described the FDA’s move as “a truly historic announcement,” adding, “This is what I’ve been looking to do for a long time.”

The FDA said convalescent plasma has so far been used to treat more than 70,000 patients in the U.S. According to a New York Times report citing two senior administration officials, the FDA was planning to issue the EUA several weeks ago, but top federal health officials — including Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases — advised caution, claiming that available data on the treatment was too weak. But now the FDA now says that convalescent plasma may be effective in helping to improve the condition of some patients hospitalized with COVID-19.

With November’s presidential election fast approaching and his administration taking a battering from critics over its handling of the crisis, Trump is pinning his hopes on achieving a major breakthrough in the nation’s fight against the virus.

Official figures indicate that the U.S. has so far seen more than 180,000 deaths linked to COVID-19, making it the worst-affected country in the world.

Editors' Recommendations

Trevor Mogg
Contributing Editor
Not so many moons ago, Trevor moved from one tea-loving island nation that drives on the left (Britain) to another (Japan)…
If you use a VPN, don’t skip this important Windows 11 update
Microsoft Surface Laptop Go 3 rear view showing lid and logo.

It's not you; Windows is causing the issues this time. If the VPN on your Windows 11 or Windows 10 computer is having a hard time connecting, it is likely because of Microsoft's April security updates for Windows 11 (KB5036893 for) and Windows 10 (KB5036892), which have been reported to be the cause of the problems.

But there's good news. According to Microsoft, a patch is now available to fix the VPN problems users are experiencing.

Read more
This new Google Sheets feature is going to save so much time
Google Sheets is open in the Safari browser on a MacBook Air.

After Google I/O 2024, Google continues to roll out features that bolster its productivity apps -- this time, specifically with Google Sheets. As picked up by The Verge, Google has announced a much simpler way to generate easily formatted tables in the Sheets app. This new Sheets feature has been around for many years in Excel and has recently reached Google. Better late than never.

The option is called Convert to table, and you can use it by opening a Sheets document and clicking Format > Convert to table when the option reaches you later this month or early next. With this new option, Google aims for a more Excel-type experience by adding filters for each column. The rows also get visual separators, saving you time by not having to select the rows manually to turn them gray. The Convert to table feature also brings filters and column types and makes the drop-down menu creation easier.

Read more
The iPhone 16 Pro Max may get a very important battery upgrade
An iPhone 15 Pro Max laying face-down outside, showing the Natural Titanium color.

iPhone 16 dummy models Sonny Dickson / X

The iPhone 16 still has many months to go before its anticipated announcement in the fall, but we’ve already gotten a slew of rumors, leaks, and speculation about its specs and capabilities. One of the latest rumors about the iPhone 16 Pro Max comes from analyst Ming-Chi Kuo and it regards a new battery Apple is putting into the device.

Read more